While neither NonO nor SFPQ has been characterized further in lymphoma/leukemia, the aberrant functions of both have been observed in the etiology of colorectal, hepatocellular, renal, myeloid and prostate cancer ([98]; reviewed in [99]). This evidence concerns the gene NONO and prostate carcinoma.